Prism Medico Pharmacy Ltd vs Variman Global Enterprises Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Prism Medico & Pharmacy Ltd is ₹ 31.52 as of 23 Oct 15:30 . The P/E Ratio of Prism Medico & Pharmacy Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe P/E Ratio of Variman Global Enterprises Ltd changed from 47.3 on March 2021 to 16.2 on March 2026 . This represents a CAGR of -16.35% over 6 years The Market Cap of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Market Cap of Variman Global Enterprises Ltd changed from ₹ 45.14 crore on March 2021 to ₹ 53.65 crore on March 2026 . This represents a CAGR of 2.92% over 6 years The revenue of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Variman Global Enterprises Ltd for the Jun '26 is ₹ 26.06 crore as compare to the Mar '26 revenue of ₹ 44.46 crore. This represent the decline of -41.39% The ebitda of Prism Medico & Pharmacy Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Variman Global Enterprises Ltd for the Jun '26 is ₹ 2.57 crore as compare to the Mar '26 ebitda of ₹ 1.9 crore. This represent the growth of 35.26% The net profit of Prism Medico & Pharmacy Ltd changed from ₹ 0 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of 0.0% The net profit of Variman Global Enterprises Ltd changed from ₹ 0.2 crore to ₹ 1.07 crore over 9 quarters. This represents a CAGR of 110.72% The Dividend Payout of Prism Medico & Pharmacy Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Variman Global Enterprises Ltd changed from 38.05 % on March 2021 to 0 % on March 2026 . This represents a CAGR of -100.00% over 6 years .

About Prism Medico & Pharmacy Ltd

Prism Medico and Pharmacy Limited was originally incorporated under the name of Woolite Mercantile Company Limited on 21st February, 1985.
The name of the Company was changed from Woolite Mercantile Company Limited to Prism Medico and Pharmacy Limited dated January 9, 2012.
Initially, the Company was engaged into Wholesale and Retail of straw, fodder and other animal/poultry feed.
It also engaged into investments, share trading, and financial activities. Over the past years, the Company was not able to carry out any major operations, resulting it engaged in trading. During FY 2022-23, the main objects of the Memorandum of Association of the Company were altered so as to manufacture, formulate, process, develop, refine, import, export, wholesale and/or retail trade all kinds of pharmaceuticals, antibiotics, drugs, medicines, biological, neutraceuticals, healthcare, ayurvedic and dietary supplement products, medicinal preparations, vaccines, chemicals, chemical products, dry salters, mineral waters, wines, cordials, liquors, soups, broths and other restoratives or foods and also to deal in medicinal goods.

About Variman Global Enterprises Ltd

Variman Global Enterprises Limited was erstwhile incorporated as 'Spring fields Securities Limited' in December 1993.
Name of the Company was changed from Spring Field Securities Limited to 'Spring Fields Infraventures Limited' in 2015 and again was changed from Spring Fields Infraventures Limited to 'Variman Global Enterprises Limited' w.e.f. 16 December 2019. The Company started its commercial operations in 1993 and is a leading IT infrastructure solutions provider through software development, IT Infrastructure solutions and distributing IT Hardware to clients and partners through aggressive market development in Telangana.
It is presently engaged in distribution of HPMPS division and EATON Power Solutions.
Apart from these, Variman portfolio includes end user computing from Desktops, laptops, server and server room technologies, printing, imaging and scanning solutions, networking solutions, wireless technologies, security & firewall solutions to IT infrastructure.

FAQs for the comparison of Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd

Which company has a larger market capitalization, Prism Medico & Pharmacy Ltd or Variman Global Enterprises Ltd?

Market cap of Prism Medico & Pharmacy Ltd is 42 Cr while Market cap of Variman Global Enterprises Ltd is 75 Cr

What are the key factors driving the stock performance of Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd?

The stock performance of Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd?

As of October 25, 2026, the Prism Medico & Pharmacy Ltd stock price is INR ₹31.52. On the other hand, Variman Global Enterprises Ltd stock price is INR ₹3.85.

How do dividend payouts of Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd compare?

To compare the dividend payouts of Prism Medico & Pharmacy Ltd and Variman Global Enterprises Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.